IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Cosentini, Deborah
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.987
EU - Europa 1.371
AS - Asia 888
SA - Sud America 10
AF - Africa 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.972
IT - Italia 318
PL - Polonia 315
SG - Singapore 288
CN - Cina 210
HK - Hong Kong 202
DE - Germania 157
FI - Finlandia 143
UA - Ucraina 86
RU - Federazione Russa 79
IE - Irlanda 78
TR - Turchia 65
CZ - Repubblica Ceca 39
GB - Regno Unito 38
ID - Indonesia 36
SE - Svezia 29
VN - Vietnam 28
BE - Belgio 26
IN - India 25
FR - Francia 21
JP - Giappone 15
NL - Olanda 12
CA - Canada 11
CH - Svizzera 10
AT - Austria 6
AZ - Azerbaigian 4
PT - Portogallo 4
AR - Argentina 3
KZ - Kazakistan 3
ZA - Sudafrica 3
BR - Brasile 2
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
LV - Lettonia 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
ZW - Zimbabwe 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
ES - Italia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.265
Salva come PNG Salva come JPEG
Città #
Warsaw 315
Fairfield 275
Singapore 254
Hong Kong 201
Ashburn 191
Chandler 157
Helsinki 133
Seattle 119
Woodbridge 111
Houston 106
New York 97
Wilmington 79
Cambridge 78
Jacksonville 76
Princeton 69
Istanbul 65
Brescia 52
Dublin 44
Ann Arbor 43
Boardman 41
Moscow 41
Beijing 40
Los Angeles 40
Munich 40
Jakarta 36
Shanghai 36
Dalmine 34
Brno 32
West Jordan 30
Dong Ket 28
Milan 28
Brussels 26
Menlo Park 22
Dearborn 20
Romola 20
Nanjing 16
Naples 16
Rome 13
San Diego 13
Nuremberg 12
Pune 12
Washington 11
Des Moines 10
Gumyojicho 9
London 9
Turin 9
Nanchang 8
Lappeenranta 7
Mumbai 7
Changsha 6
Fukuoka 6
Jinan 6
Olomouc 6
Chicago 5
Dietikon 5
Perugia 5
San Francisco 5
Shenyang 5
Tianjin 5
Calcinate 4
Hebei 4
Leipzig 4
Livorno 4
Phoenix 4
Redwood City 4
Santa Clara 4
Almaty 3
Baku 3
Barberino di Mugello 3
Buenos Aires 3
Espoo 3
Falkenstein 3
Gardone Val Trompia 3
Genoa 3
Guangzhou 3
Lisbon 3
North York 3
Norwalk 3
Ottawa 3
Padova 3
Rockville 3
Toronto 3
Zhengzhou 3
Zurich 3
Augusta 2
Bergamo 2
Berlin 2
Borås 2
Brooklyn 2
Bussolengo 2
Chiswick 2
Cornuda 2
Fuzhou 2
Giussano 2
Gradara 2
Gunzenhausen 2
Hounslow 2
Huizen 2
Kunming 2
Leawood 2
Totale 3.299
Salva come PNG Salva come JPEG
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 195
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 180
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 178
Immunotherapy failure in adrenocortical cancer: where next? 167
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 159
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 155
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 152
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 134
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 127
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 126
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 114
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 114
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 112
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 109
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 104
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 99
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 88
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 85
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 83
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 78
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 74
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 66
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 63
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 57
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 56
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 54
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 53
null 51
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 50
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 50
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 50
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 46
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 46
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 44
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 43
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 42
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 41
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 41
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 38
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 37
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 36
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 36
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 36
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 35
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 34
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 34
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 33
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 33
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 32
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 31
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 31
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 31
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 29
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 28
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 27
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group 27
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 27
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 26
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 26
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 26
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 24
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 20
The Evolving Treatment Landscape of Medullary Thyroid Cancer 20
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 20
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 20
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 19
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 18
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 17
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 15
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial 15
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 14
Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019-2021 13
Adjuvant denosumab for early breast cancer-Evidence and controversy 12
Real-world use of multigene signatures in early breast cancer: differences to clinical trials 10
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 8
Totale 4.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 0 0 0 0 0 0 0 79 66 70 47 58
2020/2021768 35 88 72 91 67 74 32 68 48 88 38 67
2021/2022398 37 10 12 76 19 27 15 20 17 55 31 79
2022/2023440 50 22 27 31 36 96 4 48 56 16 29 25
2023/2024918 43 31 74 75 74 171 27 50 129 61 23 160
2024/20251.070 54 45 30 414 174 131 154 68 0 0 0 0
Totale 4.424